No Prescription |
 |
 | ||
|
FOVAS Monopril |
|
| ||
No Prescription » Prescription Drugs 8 » FOVAS Monopril Fosinopril is used alone or in combination with other medications to treat high blood pressure. It is also used in combination with other medications to treat heart failure. Fosinopril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels so blood flows more smoothly and the heart can pump blood more efficiently.Fosinopril comes as a tablet to take by mouth. It is usually taken once or twice a day. To help you remember to take fosinopril take it around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take fosinopril exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Your doctor will probably start you on a low dose of fosinopril and gradually increase your dose.Fosinopril controls high blood pressure and heart failure but does not cure them. Continue to take fosinopril even if you feel well. Do not stop taking fosinopril without talking to your doctor. Buy FOVAS Monopril and other Prescription Drugs 8 products online at Medstore. Buy Online at Medstore - Click Here!
About FOVAS Monopril: Product Type: Prescription Drugs 8 FOVAS ( Monopril GENERIC Fosinopril ) FOVAS (Monopril GENERIC Fosinopril) Monopril GENERIC Fosinopril 10 mg 200(2 x 100) Tablets 10 mg 400(4 x 100) Tablets 10 mg 100 Tablet 20 mg 400(4 x 100) Tablets 20 mg 200(2 x 100) Tablets 20 mg 100 Tablet Monopril GENERIC Fosinopril FOVAS
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
